Skip to main content
Erschienen in:

27.01.2022 | Original Article

Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis

verfasst von: Lihua Chang, Renyi Zhou

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

Rheumatoid arthritis (RA) may lead to irreversible joint damage. The role of histone modifications in RA has been emphasized. This study investigated the effect of histone methyltransferase EZH2 on fibroblast-like synoviocytes (FLSs) in RA.

Materials and methods

Synovial tissues were collected from RA patients and non-RA patients (NC). RA-FLSs and NC-FLSs were isolated and identified using flow cytometry. EZH2 expression in synovial tissues and FLSs was detected using RT-qPCR and Western blot. The proliferation, migration, and invasion of RA-FLSs and NC-FLSs were measured using MTT, EdU, and Transwell assays. The binding of EZH2, H3K27me3, and miR-22-3p was analyzed using ChIP assay. The targeting relationship between miR-22-3p and CYR61 was verified using dual-luciferase assay. miR-22-3p and CYR61 expressions were detected using RT-qPCR. CYR61 and H3K27me3 levels were detected using Western blot. Functional rescue experiments were performed to verify the effect of miR-22-3p or CYR61 on RA-FLSs.

Results

EZH2 was highly expressed in synovial tissues and FLSs from RA patients. The proliferation, migration, and invasion ability of RA-FLSs was stronger than that of NC-FLSs. Downregulation of EZH2 repressed proliferation, migration, and invasion of RA-FLSs. EZH2 inhibited miR-22-3p expression by binding to the miR-22-3p promoter and increasing H3K27me3 methylation level, and thereby upregulated CYR61 expression. Downregulation of miR-22-3p or overexpression of CYR61 annulled the inhibitory effect of EZH2 silencing on RA-FLS proliferation, migration, and invasion.

Conclusion

EZH2 bound to the miR-22-3p promoter and inhibited miR-22-3p expression by upregulating H3K27me3 level, thereby promoting CYR61 expression and inducing the proliferation, migration, and invasion of RA-FLSs.
Literatur
2.
Zurück zum Zitat Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320:1360–1372PubMedCrossRef Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320:1360–1372PubMedCrossRef
3.
Zurück zum Zitat Choy EH, Kavanaugh AF, Jones SA (2013) The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol 9:154–163PubMedCrossRef Choy EH, Kavanaugh AF, Jones SA (2013) The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol 9:154–163PubMedCrossRef
4.
Zurück zum Zitat Nygaard G, Firestein GS (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16:316–333PubMedPubMedCentralCrossRef Nygaard G, Firestein GS (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16:316–333PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, Kim J (2020) Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 22:275PubMedPubMedCentralCrossRef Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, Kim J (2020) Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 22:275PubMedPubMedCentralCrossRef
7.
8.
Zurück zum Zitat Nemtsova MV, Zaletaev DV, Bure IV, Mikhaylenko DS, Kuznetsova EB, Alekseeva EA, Beloukhova MI, Deviatkin AA, Lukashev AN, Zamyatnin AA Jr (2019) Epigenetic changes in the pathogenesis of rheumatoid arthritis. Front Genet 10:570PubMedPubMedCentralCrossRef Nemtsova MV, Zaletaev DV, Bure IV, Mikhaylenko DS, Kuznetsova EB, Alekseeva EA, Beloukhova MI, Deviatkin AA, Lukashev AN, Zamyatnin AA Jr (2019) Epigenetic changes in the pathogenesis of rheumatoid arthritis. Front Genet 10:570PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Garcia S, Malvar Fernandez B, McKinsey TA, Tak PP, Fossati G, Mascagni P, Baeten DL, Reedquist KA (2017) Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis 76:277–285PubMedCrossRef Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Garcia S, Malvar Fernandez B, McKinsey TA, Tak PP, Fossati G, Mascagni P, Baeten DL, Reedquist KA (2017) Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis 76:277–285PubMedCrossRef
10.
Zurück zum Zitat Bottini N, Firestein GS (2013) Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 15:372PubMedCrossRef Bottini N, Firestein GS (2013) Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 15:372PubMedCrossRef
11.
Zurück zum Zitat Yuan FL, Li X, Xu RS, Jiang DL, Zhou XG (2014) DNA methylation: roles in rheumatoid arthritis. Cell Biochem Biophys 70:77–82PubMedCrossRef Yuan FL, Li X, Xu RS, Jiang DL, Zhou XG (2014) DNA methylation: roles in rheumatoid arthritis. Cell Biochem Biophys 70:77–82PubMedCrossRef
12.
Zurück zum Zitat Klein K, Gay S (2013) Epigenetic modifications in rheumatoid arthritis, a review. Curr Opin Pharmacol 13:420–425PubMedCrossRef Klein K, Gay S (2013) Epigenetic modifications in rheumatoid arthritis, a review. Curr Opin Pharmacol 13:420–425PubMedCrossRef
13.
Zurück zum Zitat Trevino LS, Wang Q, Walker CL (2015) Phosphorylation of epigenetic “readers, writers and erasers”: implications for developmental reprogramming and the epigenetic basis for health and disease. Prog Biophys Mol Biol 118:8–13PubMedPubMedCentralCrossRef Trevino LS, Wang Q, Walker CL (2015) Phosphorylation of epigenetic “readers, writers and erasers”: implications for developmental reprogramming and the epigenetic basis for health and disease. Prog Biophys Mol Biol 118:8–13PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Zhang X, Wang Y, Yuan J, Li N, Pei S, Xu J, Luo X, Mao C, Liu J, Yu T, Gan S, Zheng Q, Liang Y, Guo W, Qiu J, Constantin G, Jin J, Qin J, Xiao Y (2018) Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3. J Exp Med 215:1365–1382PubMedPubMedCentralCrossRef Zhang X, Wang Y, Yuan J, Li N, Pei S, Xu J, Luo X, Mao C, Liu J, Yu T, Gan S, Zheng Q, Liang Y, Guo W, Qiu J, Constantin G, Jin J, Qin J, Xiao Y (2018) Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3. J Exp Med 215:1365–1382PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC (2011) Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis 70:1482–1488PubMedCrossRef Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC (2011) Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis 70:1482–1488PubMedCrossRef
16.
Zurück zum Zitat Xiao XY, Li YT, Jiang X, Ji X, Lu X, Yang B, Wu LJ, Wang XH, Guo JB, Zhao LD, Fei YY, Yang HX, Zhang W, Zhang FC, Tang FL, Zhang JM, He W, Chen H, Zhang X (2020) EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis. J Autoimmun 108:102404PubMedCrossRef Xiao XY, Li YT, Jiang X, Ji X, Lu X, Yang B, Wu LJ, Wang XH, Guo JB, Zhao LD, Fei YY, Yang HX, Zhang W, Zhang FC, Tang FL, Zhang JM, He W, Chen H, Zhang X (2020) EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis. J Autoimmun 108:102404PubMedCrossRef
17.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMedCrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMedCrossRef
18.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef
19.
Zurück zum Zitat Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352PubMed Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352PubMed
20.
Zurück zum Zitat Park C, Kim GY, Jung JH, Kim WJ, Choi YH (2011) Pectenotoxin-2 induces G1 arrest of the cell cycle in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 27:783–787PubMed Park C, Kim GY, Jung JH, Kim WJ, Choi YH (2011) Pectenotoxin-2 induces G1 arrest of the cell cycle in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 27:783–787PubMed
21.
Zurück zum Zitat Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001PubMedCrossRef Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001PubMedCrossRef
22.
Zurück zum Zitat Bottini N, Firestein GS (2013) Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9:24–33PubMedCrossRef Bottini N, Firestein GS (2013) Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9:24–33PubMedCrossRef
23.
Zurück zum Zitat Smolen JS, Choe JY, Prodanovic N, Niebrzydowski J, Staykov I, Dokoupilova E, Baranauskaite A, Yatsyshyn R, Mekic M, Porawska W, Ciferska H, Jedrychowicz-Rosiak K, Zielinska A, Lee Y, Rho YH (2018) Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study. Ann Rheum Dis 77:234–240PubMedCrossRef Smolen JS, Choe JY, Prodanovic N, Niebrzydowski J, Staykov I, Dokoupilova E, Baranauskaite A, Yatsyshyn R, Mekic M, Porawska W, Ciferska H, Jedrychowicz-Rosiak K, Zielinska A, Lee Y, Rho YH (2018) Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study. Ann Rheum Dis 77:234–240PubMedCrossRef
24.
Zurück zum Zitat Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039–1043PubMedCrossRef Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039–1043PubMedCrossRef
25.
Zurück zum Zitat Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Gen Dev 16:2893–2905CrossRef Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Gen Dev 16:2893–2905CrossRef
26.
Zurück zum Zitat Cai B, Li M, Zheng Y, Yin Y, Jin F, Li X, Dong J, Jiao X, Liu X, Zhang K, Li D, Wang J, Yin G (2020) EZH2-mediated inhibition of microRNA-22 promotes differentiation of hair follicle stem cells by elevating STK40 expression. Aging (Albany NY) 12:12726–12739PubMedCentralCrossRef Cai B, Li M, Zheng Y, Yin Y, Jin F, Li X, Dong J, Jiao X, Liu X, Zhang K, Li D, Wang J, Yin G (2020) EZH2-mediated inhibition of microRNA-22 promotes differentiation of hair follicle stem cells by elevating STK40 expression. Aging (Albany NY) 12:12726–12739PubMedCentralCrossRef
27.
Zurück zum Zitat Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, He Y, Zhang J, Sun Y, Zhou Z, Wu P, Shen B, Li D, Li N (2014) A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol 66:49–59PubMedCrossRef Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, He Y, Zhang J, Sun Y, Zhou Z, Wu P, Shen B, Li D, Li N (2014) A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol 66:49–59PubMedCrossRef
28.
Zurück zum Zitat Renman E, Brink M, Arlestig L, Rantapaa-Dahlqvist S, Lejon K (2021) Dysregulated microRNA expression in rheumatoid arthritis families-a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls. Clin Rheumatol 40:2387–2394PubMedCrossRef Renman E, Brink M, Arlestig L, Rantapaa-Dahlqvist S, Lejon K (2021) Dysregulated microRNA expression in rheumatoid arthritis families-a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls. Clin Rheumatol 40:2387–2394PubMedCrossRef
29.
Zurück zum Zitat Yang QY, Yang KP, Li ZZ (2020) MiR-22 restrains proliferation of rheumatoid arthritis by targeting IL6R and may be concerned with the suppression of NF-kappaB pathway. Kaohsiung J Med Sci 36:20–26PubMedCrossRef Yang QY, Yang KP, Li ZZ (2020) MiR-22 restrains proliferation of rheumatoid arthritis by targeting IL6R and may be concerned with the suppression of NF-kappaB pathway. Kaohsiung J Med Sci 36:20–26PubMedCrossRef
30.
Zurück zum Zitat Fan Y, Yang X, Zhao J, Sun X, Xie W, Huang Y, Li G, Hao Y, Zhang Z (2019) Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis. Arthritis Res Ther 21:123PubMedPubMedCentralCrossRef Fan Y, Yang X, Zhao J, Sun X, Xie W, Huang Y, Li G, Hao Y, Zhang Z (2019) Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis. Arthritis Res Ther 21:123PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Zhai T, Gao C, Huo R, Sheng H, Sun S, Xie J, He Y, Gao H, Li H, Zhang J, Li H, Sun Y, Lin J, Shen B, Xiao L, Li N (2017) Cyr61 participates in the pathogenesis of rheumatoid arthritis via promoting MMP-3 expression by fibroblast-like synoviocytes. Mod Rheumatol 27:466–475PubMedCrossRef Zhai T, Gao C, Huo R, Sheng H, Sun S, Xie J, He Y, Gao H, Li H, Zhang J, Li H, Sun Y, Lin J, Shen B, Xiao L, Li N (2017) Cyr61 participates in the pathogenesis of rheumatoid arthritis via promoting MMP-3 expression by fibroblast-like synoviocytes. Mod Rheumatol 27:466–475PubMedCrossRef
32.
Zurück zum Zitat Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:110PubMedPubMedCentralCrossRef Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:110PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Karami J, Aslani S, Tahmasebi MN, Mousavi MJ, Sharafat Vaziri A, Jamshidi A, Farhadi E, Mahmoudi M (2020) Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease. Immunol Cell Biol 98:171–186PubMedCrossRef Karami J, Aslani S, Tahmasebi MN, Mousavi MJ, Sharafat Vaziri A, Jamshidi A, Farhadi E, Mahmoudi M (2020) Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease. Immunol Cell Biol 98:171–186PubMedCrossRef
34.
Zurück zum Zitat Hu P, Dong ZS, Zheng S, Guan X, Zhang L, Li L, Liu Z (2021) The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) via targeting EZH2. Tissue Cell 72:101591PubMedCrossRef Hu P, Dong ZS, Zheng S, Guan X, Zhang L, Li L, Liu Z (2021) The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) via targeting EZH2. Tissue Cell 72:101591PubMedCrossRef
35.
Zurück zum Zitat Ye Z, Xu J, Li S, Cai C, Li T, Sun L (2017) LncIL7R promotes the growth of fibroblastlike synoviocytes through interaction with enhancer of zeste homolog 2 in rheumatoid arthritis. Mol Med Rep 15:1412–1418PubMedCrossRef Ye Z, Xu J, Li S, Cai C, Li T, Sun L (2017) LncIL7R promotes the growth of fibroblastlike synoviocytes through interaction with enhancer of zeste homolog 2 in rheumatoid arthritis. Mol Med Rep 15:1412–1418PubMedCrossRef
37.
Zurück zum Zitat Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI (2019) MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact. Autoimmun Rev 18:102391PubMedCrossRef Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI (2019) MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact. Autoimmun Rev 18:102391PubMedCrossRef
38.
Zurück zum Zitat Chen XM, Huang QC, Yang SL, Chu YL, Yan YH, Han L, Huang Y, Huang RY (2015) Role of Micro RNAs in the pathogenesis of rheumatoid arthritis: novel perspectives based on review of the literature. Med (Baltim) 94:e1326CrossRef Chen XM, Huang QC, Yang SL, Chu YL, Yan YH, Han L, Huang Y, Huang RY (2015) Role of Micro RNAs in the pathogenesis of rheumatoid arthritis: novel perspectives based on review of the literature. Med (Baltim) 94:e1326CrossRef
39.
Zurück zum Zitat Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, Li X, Bai Y, Cheng Y (2021) MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ 766:142191PubMedCrossRef Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, Li X, Bai Y, Cheng Y (2021) MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ 766:142191PubMedCrossRef
40.
Zurück zum Zitat Tang J, Lin J, Yu Z, Jiang R, Xia J, Yang B, Ou Q, Lin J (2021) Identification of circulating miR-22–3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis. Clin Exp Rheumatol Tang J, Lin J, Yu Z, Jiang R, Xia J, Yang B, Ou Q, Lin J (2021) Identification of circulating miR-22–3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis. Clin Exp Rheumatol
41.
42.
Zurück zum Zitat Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, Kim J (2020) Correction to: Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 22:287PubMedPubMedCentralCrossRef Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, Kim J (2020) Correction to: Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 22:287PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Huang TL, Mu N, Gu JT, Shu Z, Zhang K, Zhao JK, Zhang C, Hao Q, Li WN, Zhang WQ, Liu NN, Zhang Y, Zhang W, Xue XC, Zhang YQ (2017) DDR2-CYR61-MMP1 signaling pathway promotes bone erosion in rheumatoid arthritis through regulating migration and invasion of fibroblast-like synoviocytes. J Bone Miner Res 32:407–418PubMedCrossRef Huang TL, Mu N, Gu JT, Shu Z, Zhang K, Zhao JK, Zhang C, Hao Q, Li WN, Zhang WQ, Liu NN, Zhang Y, Zhang W, Xue XC, Zhang YQ (2017) DDR2-CYR61-MMP1 signaling pathway promotes bone erosion in rheumatoid arthritis through regulating migration and invasion of fibroblast-like synoviocytes. J Bone Miner Res 32:407–418PubMedCrossRef
44.
Zurück zum Zitat Chen CY, Fuh LJ, Huang CC, Hsu CJ, Su CM, Liu SC, Lin YM, Tang CH (2017) Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy. Sci Rep 7:421PubMedPubMedCentralCrossRef Chen CY, Fuh LJ, Huang CC, Hsu CJ, Su CM, Liu SC, Lin YM, Tang CH (2017) Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy. Sci Rep 7:421PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Xu T, He YH, Wang MQ, Yao HW, Ni MM, Zhang L, Meng XM, Huang C, Ge YX, Li J (2016) Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis. Gene 592:179–185PubMedCrossRef Xu T, He YH, Wang MQ, Yao HW, Ni MM, Zhang L, Meng XM, Huang C, Ge YX, Li J (2016) Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis. Gene 592:179–185PubMedCrossRef
46.
Zurück zum Zitat Jie LG, Huang RY, Sun WF, Wei S, Chu YL, Huang QC, Du HY (2015) Role of cysteinerich angiogenic inducer 61 in fibroblastlike synovial cell proliferation and invasion in rheumatoid arthritis. Mol Med Rep 11:917–923PubMedCrossRef Jie LG, Huang RY, Sun WF, Wei S, Chu YL, Huang QC, Du HY (2015) Role of cysteinerich angiogenic inducer 61 in fibroblastlike synovial cell proliferation and invasion in rheumatoid arthritis. Mol Med Rep 11:917–923PubMedCrossRef
47.
Zurück zum Zitat Yang B, Ni J, Long H, Huang J, Yang C, Huang X (2018) IL-1beta-induced miR-34a up-regulation inhibits Cyr61 to modulate osteoarthritis chondrocyte proliferation through ADAMTS-4. J Cell Biochem 119:7959–7970PubMedCrossRef Yang B, Ni J, Long H, Huang J, Yang C, Huang X (2018) IL-1beta-induced miR-34a up-regulation inhibits Cyr61 to modulate osteoarthritis chondrocyte proliferation through ADAMTS-4. J Cell Biochem 119:7959–7970PubMedCrossRef
Metadaten
Titel
Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis
verfasst von
Lihua Chang
Renyi Zhou
Publikationsdatum
27.01.2022
Verlag
Springer Singapore
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 2/2022
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-021-01299-y

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.